22 octobre 2025|
AI
|about 1 month agoSwiss Pharmaceutical Exports to Russia Remain Stable Despite Conflict
Swiss pharma companies maintain steady export levels to Russia, citing patient care responsibilities while facing criticism over continued trade.
AI
Generated IllustrationKey Takeaways
AI
- Swiss pharmaceutical exports to Russia reached CHF 1.8 billion in 2024.
- Pharmaceutical products now account for over 80% of all Swiss exports to Russia.
- Russia represents less than 2% of the total Swiss pharmaceutical export market.
- Current EU and Swiss sanctions exempt humanitarian and medical products.
- Roche has suspended new clinical trials and the admission of new patients in Russia.
By The Numbers
CHF 1.8 billion
Total value of pharmaceutical exports to Russia in 2024
>80%
Share of pharma products in total Swiss exports to Russia
3.5 years
Duration of conflict with stable trade
~1%
Russia's share of Roche's turnover
They Said
"Following the tightening of sanctions by Western countries against Russia, Swiss pharmaceutical companies should also withdraw from Russia."
"Novartis is committed to ensuring access to medicines for people all over the world, regardless of where they are."